Endocrine disruptors in ancient times and Greek mythology: the spring of Salmacis and the curse of Hermaphroditus.

Endocrine disruptors Hermaphroditus Mycoestrogens Zearalenone (ZEA)

Journal

Hormones (Athens, Greece)
ISSN: 2520-8721
Titre abrégé: Hormones (Athens)
Pays: Switzerland
ID NLM: 101142469

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 11 10 2021
accepted: 06 07 2022
pubmed: 23 7 2022
medline: 3 12 2022
entrez: 22 7 2022
Statut: ppublish

Résumé

According to Greek mythology, the spring waters of Salmacis (or Salmakis) feminized the god Hermaphroditus (or Hermaphroditos) and transformed his nature from male to half-male and half-female. The mythical properties of these waters are described in the writings of authors and philosophers of the Hellenistic period. It is evident that the spring of Salmacis and lake actually existed (located in Halicarnassus, today Bodrum, Turkey) and are not the product of poetic imagination. Hence, it could be hypothesized that there were certain natural elements in the waters that had a feminizing effect on the male reproductive axis. We now know, in fact, that naturally occurring environmental agents, also known as endocrine disruptors, can affect the endocrine and reproductive function of both males and females. However, since most endocrine disruptors today are manmade products of the modern industrial lifestyle, the presence and effect of naturally occurring disruptors in times preceding the Industrial Revolution are not widely discussed. It is thus against this background that we seek to formulate a differential diagnosis of male feminization attributable to the effect of natural environmental factors in the form of endocrine disruptors that will have existed in environments round the globe since time immemorial. We conclude that if there had been an accumulation of the mycotoxin zearalenone (ZEA) in the waters of Salmacis, chronic exposure to the lake's water could have resulted in the phenotypic changes described in the Salmacis myth.

Identifiants

pubmed: 35869406
doi: 10.1007/s42000-022-00388-5
pii: 10.1007/s42000-022-00388-5
pmc: PMC10426231
mid: NIHMS1878485
doi:

Substances chimiques

Endocrine Disruptors 0
Zearalenone 5W827M159J

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

729-734

Subventions

Organisme : NICHD NIH HHS
ID : F32 HD108873
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Hellenic Endocrine Society.

Références

Toxins (Basel). 2021 Jan 06;13(1):
pubmed: 33418872
Birth Defects Res. 2020 Oct;112(17):1308-1325
pubmed: 32476245
Int J Mol Sci. 2008 Dec;9(12):2570-2584
pubmed: 19330093
Sci Total Environ. 2010 Dec 15;409(2):326-33
pubmed: 21056458
Environ Int. 2015 Aug;81:26-44
pubmed: 25916939
Arh Hig Rada Toksikol. 2012 Dec;63(4):429-35
pubmed: 23334037
Bull World Health Organ. 1999;77(9):754-66
pubmed: 10534900
Mycotoxin Res. 2019 Feb;35(1):27-46
pubmed: 30209771
Sci Total Environ. 2011 Nov 15;409(24):5221-7
pubmed: 21975003
Phytopathology. 2020 Jul;110(7):1312-1318
pubmed: 32223642
Environ Toxicol. 2013 May;28(5):276-89
pubmed: 21695757
Environ Toxicol Pharmacol. 2016 Dec;48:141-149
pubmed: 27771507
J Agric Food Chem. 2007 Oct 17;55(21):8339-45
pubmed: 17894460
Environ Int. 2015 Oct;83:11-40
pubmed: 26073844
Toxicon. 2019 Apr 15;162:46-56
pubmed: 30851274

Auteurs

Vasiliki Vasileiou (V)

1st Department of Endocrinology, Diabetes Centre "Alexandra" Hospital, Athens, Greece.

Georgios K Markantes (GK)

Division of Endocrinology, Department of Internal Medicine, University of Patras School of Health Sciences, Rio, Patras, Greece.

Maria I Stamou (MI)

Harvard Reproductive Sciences Center, Massachusetts General Hospital, Boston, MA, USA.

Neoklis A Georgopoulos (NA)

Division of Endocrinology, Department of Internal Medicine, University of Patras School of Health Sciences, Rio, Patras, Greece. neoklisgeorgo@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH